Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation
Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the effectiveness of an intervention with a
mobile adherence platform, compared to physician- or nurse-guided standard of care, to
improve medication adherence to rivaroxaban in participants who have recently initiated
treatment with rivaroxaban for stroke prevention in atrial fibrillation based on an
assessment of the proportion of days covered (PDC) of rivaroxaban treatment.